ERBB2 and breast cancer: ,9 Data from Epidemio-Strategy-Medical-Economical (ESME)-MBC database demonstrated a discordance rate of 11.1% and 12.5% for ER and HER2, respectively, in BCBMs as compared to the primary BC.9